Duloxetine HCL DR 30 MG cap 1000S
Ended Awarded Last action
- Contract number
- SPE2DR26F6U5L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,274
Award facts
- Contract value 100% obligated
- $4,274.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of 1,000 units of Duloxetine HCL DR 30 mg capsules, a generic antidepressant medication used to treat major depressive disorder, generalized anxiety disorder, and chronic pain conditions. This non-competitive delivery order, valued at $4,274.03 with firm fixed pricing, is set to be completed by December 12, 2025, and will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement running through December 2026 that enables the company to supply a broad range of medications and medical supplies to support military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a substantial portfolio of federal contracts with the Defense Logistics Agency covering diverse therapeutic domains including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. The company's consistent awards through competitive procurement processes and its role as a prime vendor across multiple DLA contracts underscore its critical position in the federal medical supply chain, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F6U5L?
SPE2DR26F6U5L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26F6U5L worth?
The government has obligated $4,274 on SPE2DR26F6U5L.
Is contract SPE2DR26F6U5L an order under another contract?
Yes. SPE2DR26F6U5L is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6U5L competed?
The extent of competition for SPE2DR26F6U5L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award